Upstream Bio, Inc. (UPB)
NASDAQ: UPB · Real-Time Price · USD
24.53
+1.19 (5.10%)
Nov 14, 2025, 4:00 PM EST - Market closed
Upstream Bio Stock Forecast
Stock Price Forecast
The 1 analyst with a 12-month price forecast for Upstream Bio stock has a target of 47, which predicts a 91.60% increase from the current stock price of 24.53.
Price Target: $47 (+91.60%)
Analyst Consensus: Strong Buy
* Price targets were last updated on Oct 14, 2025.
Analyst Ratings
According to 1 stock analyst, the rating for Upstream Bio is "Strong Buy". This means that the analyst believes this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jun '25 | Jul '25 | Aug '25 | Sep '25 | Oct '25 | Nov '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 2 | 1 |
| Buy | 3 | 3 | 3 | 3 | 3 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 4 | 4 | 4 | 5 | 1 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Truist Securities | Truist Securities | Strong Buy Initiates $47 | Strong Buy | Initiates | $47 | +91.60% | Oct 14, 2025 |
| JP Morgan | JP Morgan | Buy Initiates $38 | Buy | Initiates | $38 | +54.91% | Nov 5, 2024 |
| William Blair | William Blair | Buy Initiates n/a | Buy | Initiates | n/a | n/a | Nov 5, 2024 |
| TD Cowen | TD Cowen | Strong Buy Initiates n/a | Strong Buy | Initiates | n/a | n/a | Nov 5, 2024 |
| Piper Sandler | Piper Sandler | Buy Initiates $75 | Buy | Initiates | $75 | +205.75% | Nov 5, 2024 |
Financial Forecast
Revenue This Year
2.47M
from 2.37M
Increased by 4.14%
Revenue Next Year
1.23M
from 2.47M
Decreased by -50.16%
EPS This Year
-2.85
from -5.58
EPS Next Year
-3.31
from -2.85
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 3.7M | 3.6M | |||
| Avg | 2.5M | 1.2M | |||
| Low | 1.5M | n/a |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 55.9% | 44.2% | |||
| Avg | 4.1% | -50.2% | |||
| Low | -38.0% | - |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -2.73 | -2.80 | |||
| Avg | -2.85 | -3.31 | |||
| Low | -2.91 | -4.48 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | |||
| Avg | - | - | |||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.